期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Advances in traditional Chinese medicine for liver disease therapy in 2021 被引量:1
1
作者 jun-yu luo Jia-Bao Liao +6 位作者 Yu-Ming Wang Jie Zhao Xue-Hua Xie Fei Qu Xi-Xing Fang Wei-Bo Wen Shu-Quan Lyu 《Traditional Medicine Research》 2022年第6期100-117,共18页
Liver diseases and their co-morbidities represent a major public health problem.Owing to its progressive pathogenesis and lack of effective treatment,liver disease has become one of the most important causes of death ... Liver diseases and their co-morbidities represent a major public health problem.Owing to its progressive pathogenesis and lack of effective treatment,liver disease has become one of the most important causes of death worldwide.Traditional Chinese medicine(TCM)has potential advantages in the prevention and treatment of liver diseases,including high safety,remarkable curative effects,and low toxicity and side effects.In 2021,TCM extracts and their derivatives,TCM compounds,and ethnic medicines showed good efficacy in the treatment of liver diseases.The main mechanisms and representative drugs of TCM can be summarized by the use of amygdalin,dicoumarol,quercetin,and ancient ephedrine decoction to treat hepatitis by inhibiting viral replication,as well as the use of Gentianae Radix,lupeol,Zornia diphylla(L.)Pers.,and Chinese patent medicine Liuwei Wuling tablet to alleviate acute liver injury by improving oxidative stress and inflammatory responses in the body.In the treatment of alcoholic liver disease and metabolic-associated fatty liver disease,the mechanism of TCM is the inhibition of oxidative stress,improving metabolism,regulating intestinal microflora,and enhancing intestinal barrier function.The representative TCM for alcoholic liver disease includes astragaloside,puerarin,patchouli alcohol,and Mori Fructus polysaccharide,while those for metabolic-associated fatty liver disease include saikosaponin,dehydroabietic acid,hesperetin,berberine,and Panax Notoginseng saponins.Additionally,germacrone,forsythin,geniposide,and protocatechuic acid can inhibit the activation or migration of stellate cells and improve liver fibrosis.Toosendanin,paeoniflorin,chrysin,and the classical prescription Huanglian decoction can significantly inhibit the proliferation of liver cancer cells and promote their apoptosis for the treatment of hepatocellular carcinoma.The activation of the farnesol X receptor pathway can improve bile metabolism in the liver,thus,significantly alleviating cholestatic liver disease.Its representative drugs include the TCM extracts pterostilbene and arbutin.In this review,we summarize the advances made in research on TCM used in the treatment of liver diseases in 2021,providing a reference for further development of TCM for the prevention and treatment of liver diseases. 展开更多
关键词 liver disease traditional Chinese medicine EXTRACTS therapeutic mechanism intestinal barrier intestinal flora
暂未订购
Advances in Chinese medicine treatment and research on endocrine diseases in 2021 被引量:1
2
作者 Bao-Chao Pan Hui Zhang +6 位作者 Han-Zhou Li En-Ze Yuan jun-yu luo Ting-Rui Zhang Shu-Quan Lv Wei-Bo Wen Huan-Tian Cui 《Traditional Medicine Research》 2022年第5期82-95,共14页
This paper reviews the progress in treatment regimens involving traditional Chinese medicine and research on common clinical endocrine diseases in 2021,to provide a reliable basis for the traditional Chinese medicine ... This paper reviews the progress in treatment regimens involving traditional Chinese medicine and research on common clinical endocrine diseases in 2021,to provide a reliable basis for the traditional Chinese medicine treatment of endocrine diseases.In 2021-2022,research on traditional Chinese medicine for endocrine diseases has been focused on pathogenesis.We have summarized the results of the use of traditional Chinese medicine and herbal extracts for treating common endocrine system diseases in 2021,focusing on the following aspects.(1)Chinese herbal extracts or active ingredients,such as echinatin,breviscapine,and puerarin,can treat metabolic-associated fatty liver disease by inhibiting inflammation and oxidative stress,improving lipid metabolism,and regulating intestinal flora.(2)Chinese herbal extracts or active ingredients,such as Juglandis Semen extracts,Momordica charantia saponins,and Anemarrhenae Rhizoma extracts can treat type 2 diabetes by reducing insulin resistance,improving pancreatic beta cell function,and regulating intestinal microbial disorders.(3)Chinese herbal extracts or active ingredients,such as berberine,astragaloside IV,and Scutellariae Barbatae Herba polysaccharides,can treat diabetes-related complications by improving mitochondrial function,regulating autophagy,and inhibiting apoptosis and pyroptosis.(4)Chinese herbal medicines and herbal extracts or active ingredients,such as berberrubine and Resedaodorata,can treat hyperuricemia by activating the Janus kinase 2/signal transducers and activators of transcription 3 signaling pathway and inhibiting toll-like receptor 4/NOD-like receptor family,pyrin domain-containing protein 3 signaling to increase urate excretion.(5)Herbal extracts or active ingredients,such as ginsenoside Rb1,corylin,and Scutellariae Radix polysaccharides,can exert anti-obesity effects by promoting the browning of white adipocytes,activation of brown adipose tissue,and regulation of intestinal flora.(6)Chinese herbal extracts or active ingredients,such as diosgenin and Prunellae Spica extract,are able to treat thyroid-related diseases by inhibiting nucleotide-binding oligomerization domain-like receptor protein 3 inflammatory vesicle activation,regulating the expression of proliferating cell nuclear antigen,and cadherin 1,and upregulating the ubiquitination of interferon regulatory factor 4. 展开更多
关键词 endocrine metabolic diseases Chinese medicine Chinese herbal extracts therapeutic mechanisms intestinal flora
暂未订购
Advances in traditional Chinese medicine for respiratory disease therapy in 2021
3
作者 Yuan-Chong Wang Yu-Lin Wu +5 位作者 jun-yu luo Kun Wang Xue-Chao Lu Hai-Bo Hu Hong-Wu Wang Jun Kang 《Traditional Medicine Research》 2022年第4期55-65,共11页
Respiratory diseases are common conditions that endanger human health.Their etiology,pathogenesis,and prognosis are complex,and clinical research has been extensive.This paper reviews studies from the PubMed database ... Respiratory diseases are common conditions that endanger human health.Their etiology,pathogenesis,and prognosis are complex,and clinical research has been extensive.This paper reviews studies from the PubMed database to assess the progress of traditional Chinese medicine in the treatment of respiratory diseases in 2021,focusing on related animal and cell models of coronavirus disease 2019.Traditional Chinese medicine extracts,such as polysaccharides and emodin,and classic prescriptions,such as Mahuang decoction,respond to the treatment of influenza by reducing viral infections and regulating the body’s immune response.Chinese herbal extracts,such as schizandra B and andrographolide,treat asthma by inhibiting inflammatory response pathway formation,NLRP3 inflammasome formation,oxidative stress,and autophagy.Traditional Chinese medicine extracts such as fucoxanthin,and proprietary Chinese medicines such as the Xihuang pill is used in the treatment of lung cancer,as it regulates the cell cycle,inhibit tumor cell proliferation,and enhance the body’s immune function.Classic formulas such as the kidney tonic lung formula and proprietary Chinese medicine,such as compound grass stone silkworm granules,relieve airway inflammation and improve lung function in chronic obstructive pulmonary disease.Chinese herbal extracts,such as jostilbene and sage phenol,inhibit epithelial cell-mesenchymal transformation and regulate the levels of inflammatory factors to treat idiopathic pulmonary fibrosis to provide a reliable basis for the treatment of respiratory diseases. 展开更多
关键词 traditional Chinese medicine respiratory diseases research progress mechanism of action
暂未订购
Pathogenesis and treatment of diabetes mellitus-related erectile dysfunction: current therapies and potential challenges
4
作者 Han-Yu He# Fan-Yu Meng +4 位作者 Huan-Tian Cui jun-yu luo Si-Qi Ma Wei-Bo Wen Jie Zhao 《Clinical Research Communications》 2024年第2期11-17,共7页
Erectile dysfunction(ED)is one of the important complications of diabetes,which is very common in diabetic patients,affecting more than half of male patients,and the incidence of the disease is about 3.5 times that of... Erectile dysfunction(ED)is one of the important complications of diabetes,which is very common in diabetic patients,affecting more than half of male patients,and the incidence of the disease is about 3.5 times that of the normal population.The pathogenesis of diabetic erectile dysfunction(DMED)is complex,involving nerve,vascular,endocrine,muscular and psychological aspects.At present,the therapeutic approaches of DMED include drug therapy,surgery,physical therapy and so on.This article provides a review of current research on the pathogenesis and treatment of DMED.Further elucidation of the pathogenesis of DMED and the development of new therapeutic approaches are of great significance for the prevention and treatment of DMED. 展开更多
关键词 diabetes mellitus(DM) erectile dysfunction(ED) PATHOGENESIS THERAPIES
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部